ZJ Bio-Tech announced that its product, the Human Papillomavirus 23-Type Nucleic Acid Genotyping Detection Kit (Fluorescent PCR Method), has recently obtained a National Class III Medical Device Registration Certificate, valid until July 28, 2031. The product is used for in vitro qualitative detection and genotype identification of 23 HPV types in female cervical exfoliated cell samples, covering mainstream high-risk and low-risk types. This certification will enrich the company's product portfolio, enhance its molecular diagnostics product matrix, and strengthen its market competitiveness in the HPV testing field.
Shanghai ZJ Bio-Tech Co. Ltd. AProduct receives Class III medical device registration, expanding portfolio and competitiveness.